← Eichor
Condition: Plexus Choroideus Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Plexus Choroideus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Phase 3 · 21 location(s) · University of Utah · NCT04177914Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence
NA · 2 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06878469Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Gliom
Phase 1 · 1 location(s) · Seattle Children's Hospital · NCT04185038Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Phase 1 · 1 location(s) · Jazz Pharmaceuticals · NCT04541082HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Phase 1 · 3 location(s) · M.D. Anderson Cancer Center · NCT03911388Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 202
Phase N/A · 42 location(s) · European Organisation for Research and Treatment of Cancer - · NCT05259605Choroid Plexus Dysfunction in Neurological Diseases
NA · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06403189
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.